19.75
price down icon1.55%   -0.31
after-market 시간 외 거래: 20.00 0.25 +1.27%
loading

Denali Therapeutics Inc (DNLI) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
0.05%
137.37
137.43 134.96 145.58 123.19
Operating Income/Loss
0.05%
-137.37
-137.43 -134.96 -145.58 -123.19
Income/Loss From Continuing Operations Before Tax
1.22%
-128.45
-126.90 -124.12 -132.97 -107.19
Income/Loss From Continuing Operations After Tax
1.30%
-128.55
-126.90 -124.12 -132.97 -107.19
Net Income/Loss
1.30%
-128.55
-126.90 -124.12 -132.97 -107.19
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.45%
0.9469
172.42 171.45 171.22 169.46
Diluted Average Shares
99.45%
0.9469
172.42 171.45 171.22 169.46
Basic Earnings Per Share
1.35%
-0.73
-0.74 -0.72 -0.78 -0.63
Diluted Earnings Per Share
1.35%
-0.73
-0.74 -0.72 -0.78 -0.63
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$99.29
price up icon 1.20%
$27.80
price up icon 0.00%
$52.37
price down icon 0.06%
$89.31
price down icon 0.77%
$144.00
price up icon 0.91%
biotechnology ONC
$282.72
price up icon 0.15%
자본화:     |  볼륨(24시간):